Skip to content

Stephen Feider, Chief Financial Officer at Beta Bionics, sold BBNX on Jun 29, 2026

Data as of Oct 16

▼ SELL$83.4K4,896 shares at $17.03Stephen Feider Chief Financial OfficerBBNX Beta Bionics, Inc.
Watch BBNX
Traded
Jun 29, 2026
Disclosed
Jun 30, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Stephen Feider, Chief Financial Officer at Beta Bionics, sold BBNX on Jun 29, 2026TRADEDDISCLOSED
BBNXSimilar stocks (XLV — its sector index fund), rebased to BBNX's price on the disclosure day
BBNX since disclosure
+4.3%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund

Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLStephen Feider Chief Financial OfficerBBNX Beta Bionics, Inc.$87Kdisclosed Jun 30 · filed 4 days after the trade

See every trade on BBNX →